Regina Dawkins
Regina Dawkins is Associate Director/Senior Consultant, PharmaLex. She is an experienced Director/Senior Manager with 30 years in the pharma industry, working across the UK and Ireland.
FocusBrexit − Regulatory and supply chain considerations
The UK formally left the EU on 31 January 2020 and the transition period, as set out in the withdrawal agreement, came to an end on 31 December 2020. During this transition period, the UK continued to remain under EU pharmaceutical law. From 1 January 2021, the UK adopted an ...